Byung Kook Lee1, Hyun Ho Ryu. 1. Department of Emergency Medicine, Chonnam National University Hospital, Gwangju, Republic of Korea.
Abstract
BACKGROUND: Pylephlebitis, which has high rates of morbidity and mortality, is thrombosis in the hepatic and portal veins. Hypercoagulability and intra-abdominal sepsis can lead to pylephlebitis, which can progress to liver abscess, mesenteric ischemia, and infarction. CASE REPORT: A 47-year-old man presented to the Emergency Department complaining of fever, epigastric pain, and jaundice. He was diagnosed with pylephlebitis secondary to diverticulitis, as well as having a diverticular abscess, and was treated with antibiotic therapy without surgery or anticoagulation. CONCLUSION: Early diagnosis is essential for the treatment of pylephlebitis. Antibiotics and anticoagulants are the mainstay of treatment for pylephlebitis; although the use of anticoagulants remains controversial. In the present case, pylephlebitis was treated successfully without anticoagulants.
BACKGROUND: Pylephlebitis, which has high rates of morbidity and mortality, is thrombosis in the hepatic and portal veins. Hypercoagulability and intra-abdominal sepsis can lead to pylephlebitis, which can progress to liver abscess, mesenteric ischemia, and infarction. CASE REPORT: A 47-year-old man presented to the Emergency Department complaining of fever, epigastric pain, and jaundice. He was diagnosed with pylephlebitis secondary to diverticulitis, as well as having a diverticular abscess, and was treated with antibiotic therapy without surgery or anticoagulation. CONCLUSION: Early diagnosis is essential for the treatment of pylephlebitis. Antibiotics and anticoagulants are the mainstay of treatment for pylephlebitis; although the use of anticoagulants remains controversial. In the present case, pylephlebitis was treated successfully without anticoagulants.
Authors: Asad J Choudhry; Yaser M K Baghdadi; Mahmoud A Amr; Mohammad J Alzghari; Donald H Jenkins; Martin D Zielinski Journal: J Gastrointest Surg Date: 2015-07-10 Impact factor: 3.452
Authors: Dorde Jevtic; Tatjana Gavrancic; Ivana Pantic; Terri Nordin; Charles W Nordstrom; Marina Antic; Nikola Pantic; Marija Kaljevic; Bojan Joksimovic; Milan Jovanovic; Emilia Petcu; Mladen Jecmenica; Tamara Milovanovic; Lawrence Sprecher; Igor Dumic Journal: J Clin Med Date: 2022-08-25 Impact factor: 4.964